Table 2.
BRAF | NRAS | |||
---|---|---|---|---|
BRAF mutations (n = 23) |
No BRAF mutation (n = 30) |
NRAS mutation (n = 2) |
No NRAS mutation (n = 51) |
|
T1a
(n = 18) |
11 | 7 | – | 18 |
T1b
(n = 13) |
6 | 7 | 1 | 12 |
T2
(n = 9) |
2 | 7 | 1 | 8 |
T3
(n = 13) |
4 | 9 | – | 13 |
N0
(n = 39) |
16 | 23 | 2 | 37 |
N1a
(n = 8) |
5 | 3 | – | 8 |
N1b
(n = 6) |
2 | 4 | – | 6 |
n number of cases, BRAF B-type Raf kinase, NRAS Neuroblastoma RAS Viral Oncogene Homolog